SciQuest Dips 1% on 3 Million Share Offering
SciQuest (NASDAQ:SQI) said it is starting an underwritten public offering of 3,000,000 shares of common stock pursuant to an effective shelf registration statement. The last reported sale price of the company’s common stock on March 21, 2014 was $30.41 per share. The company also intends to grant the underwriters an option to purchase up to 450,000 additional shares of common stock. The company expects to … Continue reading SciQuest Dips 1% on 3 Million Share Offering
Gold Miners In News: Goldcorp Inc. (USA) (NYSE:GG), Newmont Mining Corp (NYSE:NEM), New Gold (NYSEMKT:NGD), Barrick Gold (NYSE:ABX)
Analysts at Credit Suisse upgraded shares of Goldcorp Inc. (USA) (NYSE:GG) from a “neutral” rating to an “outperform” rating in a research note on Thursday, March 13th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Goldcorp Inc. (USA) (NYSE:GG) in a research note on Thursday, March 6th. Goldcorp Inc. (USA) (NYSE:GG) stock performance was -0.04% in last session and finished the day … Continue reading Gold Miners In News: Goldcorp Inc. (USA) (NYSE:GG), Newmont Mining Corp (NYSE:NEM), New Gold (NYSEMKT:NGD), Barrick Gold (NYSE:ABX)
Trending Stocks: Yelp Inc (NYSE:YELP), Lululemon Athletica inc. (NASDAQ:LULU), Sky-mobi (NASDAQ:MOBI), Synergy Pharmaceuticals Inc (NASDAQ:SGYP)
Marissa Mayer’s tenure at Yahoo Inc. (NASDAQ:YHOO) has been quite eventful with a few high profile acquisitions and a change to the iconic Yahoo! logo. After being appointed as the President and CEO on July 16, 2012, she has overseen the purchase of Tumblr for $1.1 billion, Summly for $30 million, RockMelt, and a partnership with Yelp Inc (NYSE:YELP) announced on March 12, 2014. Yelp … Continue reading Trending Stocks: Yelp Inc (NYSE:YELP), Lululemon Athletica inc. (NASDAQ:LULU), Sky-mobi (NASDAQ:MOBI), Synergy Pharmaceuticals Inc (NASDAQ:SGYP)
Stocks to Watch on Monday: Regeneron Pharmaceuticals (NASDAQ:REGN), Symantec Corporation (NASDAQ:SYMC), Hewlett-Packard (NYSE:HPQ), First Solar (NASDAQ:FSLR)
Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) and Novartis (NYSE: NVS ) enjoy little competition for their vision-improving drugs Eylea and Lucentis. As a result, sales of Eylea grew to more than $1.8 billion last year, just two years after winning FDA approval in 2011, and sales of Novartis and Roche’s (NASDAQOTH: RHHBY ) Lucentis, which was first approved in 2006, have climbed to more than … Continue reading Stocks to Watch on Monday: Regeneron Pharmaceuticals (NASDAQ:REGN), Symantec Corporation (NASDAQ:SYMC), Hewlett-Packard (NYSE:HPQ), First Solar (NASDAQ:FSLR)
Unusual Volume At Nasdaq: Arch Capital Group (NASDAQ:ACGL), Criteo (NASDAQ:CRTO), Wintrust Financial (NASDAQ:WTFC), UMB Financial (NASDAQ:UMBF)
Criteo S.A. (ADR) (NASDAQ:CRTO) announced that it has commenced a public offering of 5,250,000 American Depository Shares, or ADSs, each representing one of Criteo S.A. (ADR) (NASDAQ:CRTO)’s ordinary shares. Criteo SA (ADR) (NASDAQ:CRTO) dropped -3.54 percent to $43.89 Friday on volume of 2.84million shares. The intra-day range of the stock was $42.77 to $44.94. Criteo SA (ADR) (NASDAQ:CRTO) has a market capitalization of $2.50billion. Wintrust … Continue reading Unusual Volume At Nasdaq: Arch Capital Group (NASDAQ:ACGL), Criteo (NASDAQ:CRTO), Wintrust Financial (NASDAQ:WTFC), UMB Financial (NASDAQ:UMBF)
NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)
Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) dropped -6.61 percent to $26.01 Friday on volume of 3.37million shares. The intra-day range of the stock was … Continue reading NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)
